Stocks to Watch: Altera, Apple, Countrywide, Intel, Johnson & Johnson
Thursday's top stories and stocks with potential to move...
Stocks to watch for Thursday, September 6, 2007:
- Altera (ALTR), stuck to its third-quarter revenue target. The company said revenue will be flat to up 3% from the three months ended June 29. This puts Altera sales in the range of $319.7 million to $329.3 million. Separately, Altera said it secured a five-year $750 million unsecured credit facility, of which it plans to use $500 mln to fund common stock repurchases.
- American Eagle Outfitter's (AEO) August same-store sales grew 9%, compared with an increase of 16% a year ago. Analysts polled by Thomson Financial, on average, expected same-store sales growth of 6%. For the four weeks ended Sept. 1, total sales rose 13% to $311.3 million from $276.6 million in the prior-year period.
- Anadigics (ANAD) acquired Fairchild Semiconductor International's (FCS) RF design team for $2.3 million. The acquisition included leases, software and licenses to intellectual property as well as the hiring of 23 RF design and engineering employees.
- Apple's (AAPL) iPhone price reduction from $599 to $399 yesterday was seen by investors as a sign of weakness, sending shares down 5.1%.
- Countrywide Financial (CFC) announced an additional 900 job cuts as the home-mortgage lender reduces costs in the face of a drop in lending volumes and rising defaults.
- Hot Topic's (HOTT) August same-store sales, or sales at stores open at least a year, fell 1.1%. On average, analysts polled by Thomson Financial expected a 2.5% drop.
- Intel's (INTC) new high-end line of chips for server systems, the Xeon, has been overhauled ahead of its launch. The company expects the product to take a piece of the niche market from Advanced Micro Devices (AMD).
- J.C. Penney's (JCP) August same-store sales at its department stores, or sales at stores open at least a year, fell 4% from a year earlier, which the company attributed to an early back-to-school sales week that was counted in July's sales figures. The retailer said total company sales fell 1.1% to $1.56 billion.
- Johnson & Johnson (JNJ) called off plans to seek a broader list of approved uses for its drug Procrit. The drug failed to show a reduction in the need for red-blood-cell transfusions among critically ill patients.
- Zumiez's (ZUMZ) August same-store sales rose 17.4%. The specialty retailer said total sales for the four weeks ended Sept. 1 increased 39.7% to $47 million from $33.7 million last year.
- Asian trading closed with the Hang Seng -0.08%, Nikkei +0.61%, Sensex +1.10%, Taiwan +1.16% and Shanghai +1.56%.
- A quick check across the pond finds the CAC -0.57%, DAX -0.62%, FTSE -0.70%, ATX -0.42%, Swiss Mkt. -0.77% and Stockholm -0.83%.
- Crude oil is trading higher +0.41 to 76.14 and gold is also higher +2.7 to 693.4 this morning.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter